Treatment of Dandruff with Topical Citrus Limon Juice
Phase 2
- Conditions
- Health Condition 1: L218- Other seborrheic dermatitis
- Registration Number
- CTRI/2022/05/042375
- Lead Sponsor
- uqman Unani Medical College Hospital and Research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients clinically diagnosed with active adherent dandruff of the scalp.
2)Patients having ASFS 6-34.16
3)Patient whose previous treatment for HazÄ?z (pityriasis capitis) ended/stopped
before 14 days
4)Willing and able to participate in the trial as an outpatient and comply with all trial requirements.
Exclusion Criteria
1)Pregnant or lactating women.
2)Other inflammatory skin disease in the treatment area that may confound the evaluation of the HazÄ?z (pityriasis capitis) (e.g., atopic dermatitis, tinea capitis and psoriasis)
3)Patients with damaged scalp.
4)Patients with history or presence of any serious disease including immunological conditions like HIV, current malignancies, diabetes mellitus. Hypertension, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: Decrease in Adherent Scalp Flaking Score (ASFS) from baseline to the end of treatment.Timepoint: At baseline, 1st week, 2nd week, 3rd week and 4th week.
- Secondary Outcome Measures
Name Time Method Decrease in Dermatology Life Quality Index (DLQI) <br/ ><br>Decrease in Investigatorsâ?? Global Assessment (IGA) for pruritus.Timepoint: At baseline and 4th week.